Katrine Fabricius
Horsholm, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Untreated Patients Dying With AIDS Have Loss of Neocortical Neurons and Glia Cells.
Journal: Frontiers in neuroscience
Published: October 24, 2019
Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease.
Journal: Disease models & mechanisms
Published: September 06, 2019
Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice.
Journal: Scientific reports
Published: June 20, 2019
Adrenomedullin and glucagon-like peptide-1 have additive effects on food intake in mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 13, 2018
Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease.
Journal: Frontiers in neuroanatomy
Published: August 01, 2017
Neocortical Development in Brain of Young Children-A Stereological Study.
Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: June 03, 2016
Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Journal: Brain research
Published: January 28, 2016
The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
Journal: Brain research
Published: August 26, 2015
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: April 15, 2015
Last Updated: 09/26/2026